Strengths & Limitations Flashcards

(30 cards)

1
Q

Why is a Newcastle-Ottawa score of 9/9 important?

A

Indicates maximum quality on selection, comparability & outcome domains → low risk of bias for a cohort design.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Which three formal quality scores did you use to report this studu?

A

Newcastle-Ottawa = 9/9; Downs & Black = 24/28; Jadad = 1/5.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Largest methodological strength of this study (one phrase)?

A

Very large, prospective UK Biobank cohort with 17 926 pre-DM + 7 798 DM followed ≈ 10 y.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How did multiple 24-h recalls strengthen diet assessment?

A

Averaging up to 5 WebQs reduced day-to-day error and better reflected long-term intake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Key statistical model used & why appropriate?

A

Cox proportional-hazards (time-to-event, handles censoring).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name two covariate blocks included in Model 2.

A

Socio-demographics (income, TDI) and lifestyle (smoking, alcohol, PA) ± clinical history.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Follow-up duration (strength)?

A

Mean ≈ 9.9 y (pre-DM) / 9.6 y (DM) → captures incident CVD with latency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What novel analyses added mechanistic depth?

A

Decomposition (dietary components) and mediation (serum biomarkers).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give one example of a successful sensitivity test.

A

Excluding events within 2 y of baseline did not change uPDI or hPDI estimates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does stratified analysis add credibility?

A

Consistent associations across age, sex, income, BMI, etc. reduces concern of effect-modifier bias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Main limitation related to diet measurement?

A

Self-reported 24-h recall → recall bias & portion size not captured.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why can timing of biomarkers vs diet be a weakness?

A

Bloods drawn before diet survey → temporal mismatch weakens mediation causality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain “residual confounding” in this context.

A

Even after extensive adjustment, unmeasured factors (e.g., sleep, stress) could influence CVD risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Selection bias introduced by attrition?

A

70 % of pre-DM and 75 % of DM excluded; remaining sample likely healthier & more health-conscious.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Generalizability caveat noted by authors?

A

UK Biobank is mostly White; associations may differ in other ethnicities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why were gestational-DM cases excluded, and why a limitation?

A

Different pathophysiology; but exclusion prevents insights for younger women.

16
Q

Interpret Jadad 1/5 score for an observational study.

A

Low because Jadad is RCT-focused; not inherently a flaw but shows tool mis-fit.

17
Q

What confounder was adjusted only for diabetes cohort?

A

Disease duration.

18
Q

Why is single-country food environment both strength & weakness?

A

Uniform food supply aids internal validity, but limits cross-cultural relevance.

19
Q

Potential implementation barrier from results?

A

Need to swap refined carbs/SSBs for whole-grains may be costly & require behaviour change support.

20
Q

How does ‘healthy-volunteer bias’ affect findings?

A

UK Biobank participants are healthier & wealthier than average → may underestimate true risk.

21
Q

List two cost-neutral strengths of study design.

A

(1) Uses routinely-linked ICD-10 hospital data; (2) Web-based diet recall saves resources.

22
Q

Why is lack of portion-size data clinically relevant?

A

Makes it hard to translate quintile scoring into real-world serving advice.

23
Q

Which exclusion criterion reduces reverse causality?

A

Dropping participants who developed CVD within 2 y of baseline.

24
Give an example of “over-adjustment” risk.
Controlling for BMI may attenuate diet→CVD effects when BMI lies on the causal pathway.
25
Why is small T1D sample noted as limitation?
Study under-powered to test whether results apply equally to type 1 diabetes.
26
Quality-control step for dietary extremes?
Removed intakes < 600 & > 4 200 kcal (men) / < 500 & > 3 600 kcal (women).
27
Mediator explaining largest share of uPDI-CVD link?
Cystatin C: 15 % (pre-DM) / 44 % (DM).
28
Examiner-style Q: “Why trust causality if design isn’t RCT?” – best rebuttal?
Temporal order (diet → incident CVD), dose-response, biological plausibility & consistent sensitivity checks strengthen inference despite observational design.
29
Take-home mantra for this slide?
“Big, long & deeply-adjusted — but still observational and self-reported.”